Haemonetics (HAE) Tops Q2 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Haemonetics (HAE) Tops Q2 EPS by 5c

Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance

November 4, 2015 6:00 AM EST

BRAINTREE, Mass., Nov. 4, 2015 /PRNewswire/ --

Product Growth Highlights

8% constant currency revenue increases in growth drivers in the second quarter, including:

11% growth in North America plasma disposables revenue 25% growth in TEG® diagnostics disposables revenue 6% growth in Emerging Markets disposables revenue, ex-Russia

Haemonetics Corporation (NYSE: HAE) reported second quarter fiscal 2016 revenue of $219.7 million, down 3%.  Revenue was flat with the second quarter of fiscal 2015 in constant currency. 

The Company reported GAAP net income of $12.9 million and GAAP net earnings per share of $0.25 in the second quarter of... More